# Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain

> **NCT05161468** · PHASE4 · TERMINATED · sponsor: **Brooke Army Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Acromioclavicular Sprain

## Interventions

- **DRUG:** Lidocaine injection
- **DRUG:** Corticosteroid Injection
- **DRUG:** Protein Rich Plasma(PRP) Injection

## Key facts

- **NCT ID:** NCT05161468
- **Lead sponsor:** Brooke Army Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-12
- **Primary completion:** 2025-05-12
- **Final completion:** 2025-05-12
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Funding limitation did not allow the trial to run to completion
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161468, "Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05161468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*